Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.

The study, published in the New England Journal of Medicine on Nov. 24, studied patient outcomes for three methods of defibrillation: standard defibrillation; double sequential external defibrillation ...

Researchers used an electrophysiological computer model of the heart's electrical circuits to examine the effect of the applied voltage field in multiple fibrillation-defibrillation scenarios. They ...

North Shore University Hospital’s cardiology team became the first to complete a procedure using the novel OmniaSecure ...

Among patients with refractory ventricular fibrillation (VF), survival to hospital discharge was more frequent with double sequential external defibrillation (DSED) and vector-change (VC) ...

OBJECTIVETo determine the use of epinephrine (adrenaline) before defibrillation for treatment of in-hospital cardiac arrest due to a ventricular arrhythmia and examine its association with patient ...

Cardiac fibrillation describes the deterioration of the heart’s electrical activity, which drives the heart’s periodic pumping. This electrical activity, which is usually organized, becomes ...

Defibrillation testing of implantable cardioverter–defibrillators (ICDs) does not improve outcomes compared with device implantation without testing and, therefore, “defibrillation testing during ...

Please provide your email address to receive an email when new articles are posted on . A novel defibrillation lead beat safety and efficacy goals in a pivotal trial. The goal of physicians is for the ...

Using light pulses as a model for electrical defibrillation, scientists developed a method to assess and modulate the heart function. The research team has thus paved the way for an efficient and ...

Mortality after out-of-hospital cardiac arrest from ventricular fibrillation is high. Programs focusing on early defibrillation have improved the rate of survival to hospital discharge. We conducted a ...

Among recipients of subcutaneous implantable cardioverter defibrillators, the omission of defibrillation testing (DT) was not associated with significant differences in mortality, or in the rates of ...